|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 18, 2017 ) Contraception, popularly known as birth control or fertility control, is used to prevent pregnancy. There are various temporary and permanent contraceptive methods and devices available in the market. Sterilization is a permanent method that almost eliminates the chances of pregnancy. Temporary methods can either be hormonal or non-hormonal. Hormonal methods include oral contraceptive pills, contraceptive transdermal patches, vaginal rings, hormonal IUDs, and vaginal implants. These methods use synthetic sex hormones - estrogen, progestin, or a combination of both - to prevent ovulation and thicken the cervical mucus. Non-hormonal methods include condoms, cervical caps, diaphragms, non-hormonal IUDs, sponges, and withdrawal methods.
Publisher's analysts forecast the global female contraceptive market to grow at a CAGR of 3.0% over the period 2014-2019.
For more information http://www.reportsweb.com/global-female-contraceptives-market-2015-2019
This report covers the present scenario and the growth prospects of the global female contraceptive market for the period 2015-2019. This report considers 2014 as the base year and provides data for the trailing 12 months.
This report covers the following types of female contraceptive:
Devices (IUDs, Sterilization, Subdermal contraceptive implants, Vaginal rings, Female condoms, Non-surgical permanent contraception, Contraceptive diaphragms, and Contraceptive sponges)
Drugs (Birth control pills and Emergency pills)
Publisher's report, Global Female Contraceptive Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, APAC, and EMEA; it also covers the landscape of the global female contraceptive market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions
Americas
APAC
EMEA
Key vendors
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001232354/sample
Allergan
Merck
Pfizer
Teva Pharmaceutical
Other prominent vendors
Ansell
Church & Dwight
Bayer
Agile Therapeutics
Caya
Fuji Latex
Janssen Pharmaceuticals
HLL Lifecare
Lipocine
Mayer Laboratories
Okamoto Industries
Reckitt Benckiser Group
Today Sponge
Female Health
Key market driver
Improved family planning
For a full, detailed list, view our report
Key market challenge
Lack of social acceptance
For a full, detailed list, view our report
Key market trend
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001232354/buying
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
